|
Safety and efficacy of inhaled IBIO123 for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1/2 trial |
|
|
|
Titel: |
Safety and efficacy of inhaled IBIO123 for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1/2 trial |
Auteur: |
Maranda, Bruno Labbé, Sébastien M Lurquin, Magali Brabant, Pascal Fugère, Alexandre Larrivée, Jean-François Grbic, Djordje Leroux, Annie Leduc, Frédéric Finzi, Andrés Gaudreau, Simon Swart, Yolandi |
Verschenen in: |
The lancet infectious diseases |
Paginering: |
Jaargang 24 () nr. 1 pagina's 25-35 |
Jaar: |
2024 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|